Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

• Main Authors: E. Molteni (Author), C. Pirone (Author), F. Ceccarelli (Author), C. Castellani (Author), C. Alessandri (Author), M. Di Franco (Author), V. Riccieri (Author), F.R. Spinelli (Author), R. Priori (Author), R. Scrivo (Author), F. Conti (Author)
• Format: Book
• Published: PAGEPress Publications, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective. Data from trials demonstrated that abatacept (ABA) has a good safety and efficacy profile in treating rheumatoid arthritis. We have studied the retention rate of ABA in a real-life cohort of patients with rheumatoid arthritis. Methods. This is a monocentric, retrospective study including...